Semaglutide Slowed Biological Aging by 2+ Years: What Men Should Know
On June 11, 2026, UC San Diego published the first randomized, placebo-controlled clinical evidence that semaglutide slows biological aging across multiple epigenetic clocks.
The Data
This isn't weight-loss marketing — it's peer-reviewed evidence from epigenetic measurement tools that quantify biological versus chronological age. For men, the longevity framing matters because it repositions GLP-1 medications from 'diet drugs' to performance optimization tools. The same medication that reduces body fat, restores testosterone, improves cardiovascular health (SELECT trial), and now demonstrably slows biological aging is arguably the most significant men's health intervention available in 2026..
What This Means for You
.
The Practical Application
.
Providers Worth Considering
Compare Men's Health Providers
Find providers that understand male-specific GLP-1 treatment needs.
View Providers →